Making Science Group SA (MS7) Ratios
Making Science Group SA Ratios
DE:MS7's free cash flow for Q4 2025 was $27.13M. For the 2025 fiscal year, DE:MS7's free cash flow was decreased by $-6.97M and operating cash flow was $34.10M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.84 | 0.75 | 0.68 | 0.94 | 1.07 |
| Quick Ratio | 0.82 | 0.73 | 0.64 | 0.91 | 1.04 |
| Cash Ratio | 0.23 | 0.16 | 0.19 | 0.36 | 0.51 |
| Solvency Ratio | 0.23 | 0.03 | 0.01 | -0.01 | 0.00 |
| Operating Cash Flow Ratio | 0.31 | 0.00 | -0.01 | 0.13 | 0.12 |
| Short-Term Operating Cash Flow Coverage | 1.31 | 0.01 | -0.04 | 0.48 | 0.50 |
| Net Current Asset Value | $ -29.63M | $ -49.37M | $ -58.24M | $ -37.53M | $ -30.13M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.22 | 0.33 | 0.32 | 0.36 | 0.42 |
| Debt-to-Equity Ratio | 1.06 | 2.20 | 2.97 | 3.30 | 3.75 |
| Debt-to-Capital Ratio | 0.51 | 0.69 | 0.75 | 0.77 | 0.79 |
| Long-Term Debt-to-Capital Ratio | 0.10 | 0.19 | 0.23 | 0.64 | 0.69 |
| Financial Leverage Ratio | 4.78 | 6.70 | 9.22 | 9.11 | 8.93 |
| Debt Service Coverage Ratio | 0.12 | 0.21 | 0.13 | 0.07 | 0.09 |
| Interest Coverage Ratio | -0.04 | 1.01 | 0.20 | -0.03 | -1.89 |
| Debt to Market Cap | 0.46 | 0.73 | 0.51 | 0.66 | 0.23 |
| Interest Debt Per Share | 5.11 | 7.11 | 6.09 | 6.70 | 5.94 |
| Net Debt to EBITDA | 2.12 | 3.29 | 3.92 | 5.17 | 6.81 |
| Profitability Margins | |||||
| Gross Profit Margin | 18.39% | 25.98% | 6.90% | 27.70% | 29.42% |
| EBIT Margin | -0.69% | 1.70% | 0.90% | -0.32% | -1.59% |
| EBITDA Margin | 1.48% | 4.08% | 2.93% | 1.56% | 1.88% |
| Operating Profit Margin | -0.05% | 1.87% | 0.41% | -0.03% | -1.35% |
| Pretax Profit Margin | -1.92% | -0.16% | -1.10% | -1.45% | -2.30% |
| Net Profit Margin | 7.13% | -0.63% | -1.61% | -2.37% | -3.16% |
| Continuous Operations Profit Margin | -2.18% | -0.53% | -1.62% | -2.17% | -2.90% |
| Net Income Per EBT | -371.48% | 396.99% | 146.68% | 163.97% | 137.21% |
| EBT Per EBIT | 3797.53% | -8.47% | -269.62% | 5035.90% | 170.89% |
| Return on Assets (ROA) | 13.55% | -1.00% | -2.62% | -3.74% | -3.30% |
| Return on Equity (ROE) | 64.79% | -6.68% | -24.18% | -34.05% | -29.51% |
| Return on Capital Employed (ROCE) | -0.33% | 10.35% | 2.38% | -0.13% | -3.21% |
| Return on Invested Capital (ROIC) | -0.20% | 5.46% | 1.23% | -0.09% | -2.44% |
| Return on Tangible Assets | 20.86% | -1.61% | -4.70% | -5.89% | -5.30% |
| Earnings Yield | 32.49% | -2.59% | -4.55% | -6.84% | -1.94% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.91 | 4.06 | 5.06 | 4.63 | 3.64 |
| Payables Turnover | 5.68 | 5.87 | 6.45 | 4.69 | 11.72 |
| Inventory Turnover | 84.75 | 73.00 | 60.85 | 52.58 | 42.32 |
| Fixed Asset Turnover | 53.71 | 27.43 | 33.22 | 105.46 | 103.42 |
| Asset Turnover | 1.90 | 1.58 | 1.63 | 1.57 | 1.05 |
| Working Capital Turnover Ratio | -13.66 | -8.51 | -12.14 | -564.48 | 44.86 |
| Cash Conversion Cycle | 14.35 | 32.59 | 21.57 | 8.01 | 77.67 |
| Days of Sales Outstanding | 74.32 | 89.80 | 72.15 | 78.91 | 100.19 |
| Days of Inventory Outstanding | 4.31 | 5.00 | 6.00 | 6.94 | 8.63 |
| Days of Payables Outstanding | 64.28 | 62.22 | 56.58 | 77.84 | 31.14 |
| Operating Cycle | 78.63 | 94.80 | 78.15 | 85.85 | 108.81 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 4.58 | 0.04 | -0.18 | 1.46 | 0.95 |
| Free Cash Flow Per Share | 3.79 | -0.64 | -0.88 | 0.84 | -2.92 |
| Dividend Paid and CapEx Coverage Ratio | 5.77 | 0.06 | -0.26 | 2.35 | 0.25 |
| Capital Expenditure Coverage Ratio | 5.77 | 0.06 | -0.26 | 2.35 | 0.25 |
| Operating Cash Flow Coverage Ratio | 0.99 | 0.01 | -0.03 | 0.23 | 0.16 |
| Operating Cash Flow to Sales Ratio | 0.12 | 0.00 | -0.01 | 0.05 | 0.07 |
| Free Cash Flow Yield | 43.54% | -8.34% | -8.92% | 8.61% | -12.34% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 3.07 | -38.25 | -21.99 | -14.61 | -51.59 |
| Price-to-Sales (P/S) Ratio | 0.22 | 0.24 | 0.35 | 0.35 | 1.63 |
| Price-to-Book (P/B) Ratio | 1.99 | 2.58 | 5.32 | 4.97 | 15.22 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 2.30 | -11.99 | -11.21 | 11.61 | -8.10 |
| Price-to-Operating Cash Flow Ratio | 1.90 | 203.54 | -54.04 | 6.66 | 24.93 |
| Price-to-Earnings Growth (PEG) Ratio | -0.00 | 0.69 | 0.67 | -0.32 | 0.17 |
| Enterprise Value Multiple | 16.96 | 9.23 | 16.03 | 27.44 | 93.60 |
| Enterprise Value | 87.32M | 103.09M | 110.69M | 89.76M | 193.91M |
| EV to EBITDA | 16.96 | 9.23 | 16.03 | 27.44 | 93.60 |
| EV to Sales | 0.25 | 0.38 | 0.47 | 0.43 | 1.76 |
| EV to Free Cash Flow | 2.62 | -18.63 | -14.84 | 14.31 | -8.74 |
| EV to Operating Cash Flow | 2.17 | 316.32 | -71.56 | 8.21 | 26.88 |
| Tangible Book Value Per Share | -2.25 | -4.09 | -5.72 | -4.57 | -3.67 |
| Shareholders’ Equity Per Share | 4.36 | 2.97 | 1.86 | 1.96 | 1.56 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.14 | -2.32 | -0.48 | -0.50 | -0.26 |
| Revenue Per Share | 39.65 | 31.55 | 27.95 | 28.07 | 14.55 |
| Net Income Per Share | 2.83 | -0.20 | -0.45 | -0.67 | -0.46 |
| Tax Burden | -3.71 | 3.97 | 1.47 | 1.64 | 1.37 |
| Interest Burden | 2.79 | -0.09 | -1.22 | 4.49 | 1.45 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.61 | -0.23 | 0.41 | -3.59 | -2.84 |
Currency in EUR